Skip to main content
OpenTrials
Completed

NCT Number: NCT00273091

MODULA Modul 5 BEAT-HF

Detektion and Registration of Atrial Tachyarrhythmias at Patients with Heart Failure; What proportion of patients with CRT-therapy are affected at least temporarily by Atrial Arrhythmia?

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Herzzentrum / Klinik für Kardiologie / Robert-Koch-Allee 9

Bad Berka, Germany

About this study

How many patients with CRT-therapy are affected at least temporarily by Atrial Arrhythmia in terms of rate, characteristics and severity of atrial rhythm disturbances at patients with CRT-therapy within 12 months after implantation of a CRT-device.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient under CRT-D or CRT-P therapy

Exclusion criteria

  • patients with permanent Atrial Fibrillation

Treatment and study plan

ICD with CRT therapy

Device

permanently CRT pacing

Primary outcomes

  1. Occurrence of atrial tachycardia in CRT patients

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Boston Scientific Corporation

Industry

Collaborators

  • Guidant Corporation

Registry information

Official study title

MODULA-Study: Modul 5 / BEAT HF: Detektion and Registration of Atrial Tachyarrhythmias at Patients With Heart Failure

Important dates

Study start
2003
Study completion
2007
First posted
Jan 9, 2006
Registry last updated
Feb 23, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.